61 WILTON ROAD, 3RD FLOOR, WESTPORT, CT
Announces Pricing of $4 Million Registered Direct Offering of Common Stock
Intensity Therapeutics, Inc. Special Meeting Results - Stockholder Votes
Other Events
Amendments to Articles of Incorporation or Bylaws, Other Events
Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Announces Pricing of Public Offering
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Annual Report to Security Holders
Q2
FY 2024
Q3
Q1
FY 2023
Q2 amended
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Amended Registration Statement for Securities
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Free Writing Prospectus
SEC Staff Correspondence